Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
about
Neurological phenotypes for Down syndrome across the life spanAlzheimer's Disease in Down Syndrome.Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNICandidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndromeSemantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young AdultsAge-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD miceDown syndrome and Alzheimer's disease: Common pathways, common goals.Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerAging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer's Disease.Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatmentsProgress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Atypical aging in Down syndrome.Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.A Review of Biomarkers for Alzheimer's Disease in Down SyndromeNeuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.Cerebrovascular pathology in Down syndrome and Alzheimer disease.
P2860
Q27025698-F11FCB3C-C297-4C14-BECF-B8CE13D5B235Q30857550-CAB637A6-A4A4-4C62-BAC6-7A68454EDFC8Q34917679-ECA2E7F9-41E9-41FC-AC97-D73A977FF8CEQ35606429-ADF56485-BEE0-4621-95F6-C421CB9B5B61Q35677159-9EF7FF46-DB2E-41DE-9F46-CD5C3AE54158Q35821382-86033542-1E6F-4A0E-BAD9-E0C0D1500255Q36037548-20BF98DF-F0FE-4F8D-9430-2A895FC499E0Q36055855-94C7E8A1-EA92-40FE-8FFB-A9D3A6266A75Q36290131-2C7ABF3F-C160-4935-9FC6-3EF4D6A397CFQ36528218-A5C5DB75-BE24-4FD2-A10F-5041DF6B56A2Q36757252-9C515F9A-0D6C-4345-BE44-D6033489FC57Q36767734-E8051150-0257-4E53-9364-89D44F39F652Q36998414-30C003B3-77C3-4713-94F0-DEE018F8275EQ37102001-326239A2-878F-4EBB-9FD3-43232708B9A2Q37300264-6D7E8A25-4C93-4CCA-9B4E-26AEFE295311Q37588576-F94FCA9B-816E-4259-9064-70E4CFEF274DQ37662773-A421B0BB-6BF9-407A-B6F5-6E6784DEF06DQ37730984-5918E68F-C652-49B7-8C71-886BECE17412Q38125769-D647923F-1257-46DC-BFD4-75EA8BD9BA82Q38129325-4C99764A-1190-439E-BFFA-305C3DA1A4E9Q38312346-321EF8BD-3E04-4263-BDEB-AAC4EB0A1214Q38653406-00914BA3-30E6-4B6E-8F6D-9E2E8E32506BQ46293399-BAD7D7D8-B6E3-4C35-A951-39F7FB6439C6Q46317444-D272F76A-7490-47F4-B2D5-E48D6929E663
P2860
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@ast
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@en
type
label
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@ast
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@en
prefLabel
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@ast
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@en
P2093
P2860
P1433
P1476
Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
@en
P2093
P2860
P304
P356
10.1212/WNL.0B013E3181FB448B
P407
P577
2010-11-01T00:00:00Z